For the quarter ending 2025-09-30, PRME has $385,012K in assets. $223,191K in debts. $71,396K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 71,396 | 53,804 | ||
| Short-term investments-Nonrelated Party | 137,030 | 44,539 | ||
| Short-term investments-Related Party | 4,861 | 3,407 | ||
| Prepaid expenses | 2,493 | 3,032 | ||
| Collaboration receivable related party | - | 120 | ||
| Other current assets | 15,626 | 16,385 | ||
| Total current assets | 231,406 | 121,287 | ||
| Property and equipment, net | 22,046 | 23,828 | ||
| Operating lease right-of-use assets | 117,869 | 120,203 | ||
| Restricted cash | 13,691 | 13,691 | ||
| Total assets | 385,012 | 279,009 | ||
| Accounts payable | 9,354 | 6,378 | ||
| Accrued expenses and other current liabilities | 11,000 | 12,158 | ||
| Deferred revenue related party | 6,951 | 8,315 | ||
| Operating lease liability | 7,714 | 7,258 | ||
| Total current liabilities | 35,019 | 34,109 | ||
| Deferred revenue, net of current related party | 59,751 | 59,562 | ||
| Operating lease liability, net of current | 110,421 | 112,478 | ||
| Research and development funding liability | 18,000 | 12,000 | ||
| Total liabilities | 223,191 | 218,149 | ||
| Common stock, par value of 0.00001 per share 775,000,000 shares authorized 180,309,471 and 131,160,842 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 2 | 2 | ||
| Additional paid-in capital | 1,004,061 | 852,561 | ||
| Accumulated other comprehensive loss | 33 | -10 | ||
| Accumulated deficit | -842,275 | -791,693 | ||
| Total stockholders equity | 161,821 | 60,860 | ||
| Total liabilities and stockholders equity | 385,012 | 279,009 | ||
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME)